>
pdufa.bio

AKY-1189

Updated ยทnext FDA decision on the calendar

AKY-1189 is a Aktis Oncology, Inc. program. Its next catalyst is a Readout in Q1 2027. Every date links its source.

AKTS catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Aktis Oncology, Inc. (AKTS). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Q1 2027AKTS

Questions

When is AKY-1189's next FDA decision or readout?

The next tracked catalyst for AKY-1189 is a Readout in Q1 2027.

What happened at AKY-1189's most recent FDA decision?

No FDA decision for AKY-1189 is in our archive yet.

Who makes AKY-1189?

Aktis Oncology, Inc. (AKTS).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.